HDAC7 and inflammation: Beyond identifying an in vivo efficacious molecular probe, our findings expand the current understanding of HDAC7 as an epigenetic regulator and underscore the potential of developing isoform‐selective HDAC7 degraders as therapeutic agents for treating inflammation‐related diseases.